These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

101 related articles for article (PubMed ID: 6784571)

  • 21. [In vitro combination effects of doripenem with aminoglycoside or ciprofloxacin against Pseudomonas aeruginosa].
    Anan N; Toba S; Ito A; Nakamura R; Tsuji M
    Jpn J Antibiot; 2011 Aug; 64(4):203-16. PubMed ID: 22066345
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Effect of cation content of agar on the activity of gentamicin, tobramycin, and amikacin against Pseudomonas aeruginosa.
    Washington JA; Snyder RJ; Kohner PC; Wiltse CG; Ilstrup DM; McCall JT
    J Infect Dis; 1978 Feb; 137(2):103-11. PubMed ID: 415096
    [TBL] [Abstract][Full Text] [Related]  

  • 23. [Comparative activity of habekacin and 4 other aminoglycosides against gram-negative bacilli. Evolution of resistance].
    Reynaud AE; Coude du Foresto B; Derriennic M; Courtieu AL
    Pathol Biol (Paris); 1988 May; 36(5):435-8. PubMed ID: 3136424
    [TBL] [Abstract][Full Text] [Related]  

  • 24. A broth-disc technique for the assay of antibiotic synergism.
    Meyer M; Hofherr L
    Can J Microbiol; 1979 Nov; 25(11):1232-8. PubMed ID: 120215
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Comparison of antimicrobial susceptibilities of Pseudomonas aeruginosa isolates, with and without plaques, from two hospitals.
    Flournoy DJ; Belobraydic KA; Qadri SM
    Methods Find Exp Clin Pharmacol; 1986 Jun; 8(6):391-2. PubMed ID: 3090386
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Comparison of minimum inhibitory concentration values determined by three antimicrobic dilution methods for Pseudomonas aeruginosa.
    Woolfrey BF; Fox JM; Quall CO
    Am J Clin Pathol; 1981 Jan; 75(1):39-44. PubMed ID: 6779623
    [TBL] [Abstract][Full Text] [Related]  

  • 27. In vitro susceptibility of clinically important bacteria to amikacin: correlation of results of broth dilution and disk sensitivity tests and effect of medium composition.
    Linzenmeier G; Naumann P; Neussel H; Rosin H
    J Infect Dis; 1976 Nov; 134 SUPPL():S262-70. PubMed ID: 825584
    [TBL] [Abstract][Full Text] [Related]  

  • 28. A laboratory assessment of the activities of four aminoglycosides.
    Schrire L; Robinson RG; Koornhof HJ
    S Afr Med J; 1984 Jun; 65(23):922-4. PubMed ID: 6427946
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Compiled data on aminoglycoside, foremost netilmicin susceptibility of bacterial strains.
    Juhlin I; Tunevall G
    Scand J Infect Dis Suppl; 1980; Suppl 23():39-44. PubMed ID: 6782657
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Evaluation of the E test in testing susceptibility of Pseudomonas aeruginosa to tobramycin.
    Rautelin H; Renkonen I; Renkonen OV
    Eur J Clin Microbiol Infect Dis; 1992 Feb; 11(2):177-80. PubMed ID: 1396734
    [TBL] [Abstract][Full Text] [Related]  

  • 31. [Evaluation of the "in vitro" activity of three aminoglycosides (gentamicin, tobramycin, and sisomicin) against "pseudomonas aeruginosa" strains (author's transl)].
    Berti P; Maranini B; Mazzoni P; Mori S
    Ann Sclavo; 1978; 20(5):696-706. PubMed ID: 111631
    [No Abstract]   [Full Text] [Related]  

  • 32. Comparative evaluation of the micro-media system, sceptor, and MIC-2000 microdilution methods for testing Pseudomonas aeruginosa against gentamicin, tobramycin, and amikacin.
    Woolfrey BF; Lally RT; Quall CO
    J Clin Microbiol; 1983 Feb; 17(2):312-6. PubMed ID: 6403574
    [TBL] [Abstract][Full Text] [Related]  

  • 33. In vitro synergistic effect of ciprofloxacin with aminoglycosides against multidrug resistant-Pseudomonas aeruginosa.
    Yasmin F; Akhtar N; Hameed A
    Pak J Pharm Sci; 2013 Sep; 26(5):1041-4. PubMed ID: 24035966
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Determination of antimicrobial susceptibility of Pseudomonas aeruginosa by disk diffusion and microdilution methods.
    Cox HU; Luther DG
    Am J Vet Res; 1980 Jun; 41(6):906-9. PubMed ID: 6776851
    [TBL] [Abstract][Full Text] [Related]  

  • 35. [Serological typing of strains of Pseudomonas aeruginosa. II. Correlations between the O-serotype and sensitivity to 3 aminoglycosides (tobramycin, gentamicin and sisomicin)].
    Berti P; Maranini B; Mazzoni P
    Ann Sclavo; 1980; 22(4):709-16. PubMed ID: 6787999
    [No Abstract]   [Full Text] [Related]  

  • 36. Possible impact of revisions in disc diffusion breakpoints for aminoglycosides and piperacillin/tazobactam in the 33rd edition of CLSI M100 document on clinical reporting and use in Indian settings with low susceptibility.
    Aggarwal P; Saxena S; Nagi N
    Indian J Med Microbiol; 2024; 49():100602. PubMed ID: 38697481
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Chemically defined antimicrobial susceptibility test medium for Pseudomonas aeruginosa.
    Jorgensen JH; Lee JC; Jones PM
    Antimicrob Agents Chemother; 1977 Mar; 11(3):415-9. PubMed ID: 404961
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Influence of cation supplements on activity of netilmicin against Pseudomonas aeruginosa in vitro and in vivo.
    Barry AL; Miller GH; Thornsberry C; Hare RS; Jones RN; Lorber RR; Ferraresi R; Cramer C
    Antimicrob Agents Chemother; 1987 Oct; 31(10):1514-8. PubMed ID: 3124731
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Antimicrobial susceptibility of gentamicin-resistant Pseudomonas aeruginosa.
    Yu PK; Washington JA
    Mayo Clin Proc; 1977 Dec; 52(12):802-5. PubMed ID: 413013
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Suceptibility of aminoglycoside-resistant gram-negative bacilli to amikacin: delineation of individual resistance patterns.
    Acar JF; Witchitz JL; Goldstein F; Talbot JN; Le Goffic F
    J Infect Dis; 1976 Nov; 134 SUPPL():S280-5. PubMed ID: 825587
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 6.